Given the prevalence of mutated p53 in cancer, we investigated the effects of five p53 mutations—L25-26A [26], C135Y, R249S, R273H, and R306A [27] —on p53 transactivity when co-expressed with the FL. This evidence concerns the gene TP53 and cancer.